4-(Difluoromethyl)-3-fluoropyridin-2-amine, 97.0%, 100mg

(4,4-Difluorocyclohexyl)hydrazine dihydrochloride, 98%, 100mg

(2-Oxo-1,2-dihydropyridin-3-yl)boronic acid, 95.0%, 250mg

2-METHYL-5-NITROISONICOTINIC ACID, 95.0%, 1g

(11bR)?-8,?9,?10,?11,?12,?13,?14,?15-?Octahydro-?4-?hydroxy-?2,?6-?bis(2,?4,?6-?trimethylphenyl)?-4-?oxide-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin, 97%, 50mg

1,2,4,5-Tetrachloro-3,6-dimethoxybenzene, 100mg

1-tert-Butyl 3-methyl 3-benzyl-4-oxopiperidine-1,3-dicarboxylate, 97%, 500mg

2-(Pyrrolidin-1-yl)pyridin-4-amine, 98%, 5g

Volumetric pipettes 1 brand class AS, 8 ml, 6 pieces

tert-Butyl 5-((2-(3-hydroxyphenyl)quinazolin-4-yl)amino)-1H-indazole-1-carboxylate, 98%, 50mg

2-(2-Aminothiazol-5-yl)ethanol, 95.0%, 250mg

Benzo[g]quinoxaline>98.0%(GC)1g

1-(tert-Butyl) 2-methyl (2R,3R)-3-hydroxypyrrolidine-1,2-dicarboxylate, 95%, 500mg